Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 5/26/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Shelley Boyd

Wrong Dr. Shelley Boyd?

Founding Director of the High Ris...

St. Michael's Hospital
30 Bond St.
Toronto, Ontario M5B 1W8

Company Description: St Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care...   more

Employment History

Board Memberships and Affiliations

  • Founder
    Translatum Medicus Inc.


  • MD
18 Total References
Web References
Translatum Medicus Inc. was ..., 2 May 2014 [cached]
Translatum Medicus Inc. was founded by Dr Shelley Boyd, an Ophthalmologist specializing in diseases of the retina, and scientist at St Michael's Hospital. She is an Assistant Professor in the Departments of Ophthalmology & Vision Sciences, and Adjunct Assistant Professor in the Department of Laboratory Medicine & Pathobiology, University of Toronto, and Biomedical Engineering, McMaster University, Hamilton.
In addition to her focus on science and medicine, Dr Boyd was formerly Head of the Ocular Angiogenesis Research Program worldwide for Novartis Pharmaceuticals, Switzerland, and helped bring today's treatment for wet AMD to patients around the globe.
Dr Boyd uniquely aligns her knowledge of science, medicine and the pharmaceutical industry, and combines this with her passion for patient care. She is Founding Director of the "High Risk Dry AMD Clinic" at St Michael's Hospital, Toronto, and the Ophthalmology Patient Education & Research Centre (Eye-PERC).
Latest News Tranlatum Medicus inc selected to present at BBIT Transfer Conference Dr Shelley Boyd opens Canada's first dedicated dry AMD clinic at St Michael's Hospital Dr Shelley Boyd to present new data at ARVO
The Principal Investigator, Dr. ..., 12 April 2010 [cached]
The Principal Investigator, Dr. Shelley Boyd, Clinical Scientist, Department of Ophthalmology, St. Michael's Hospital, Toronto, Canada and Assistant Professor, Department of Ophthalmology and Visual Science, University of Toronto, is a world renowned researcher into clinical therapies for the causes of loss of vision. "I am thrilled to be involved with this project for the treatment of Diabetic Retinopathy," said Dr. Boyd.
Network Researchers, 16 June 2011 [cached]
Shelley Boyd
Ophthalmology and Vision Sciences, University of Toronto
Shelley Boyd is an Assistant Professor in the Department of Ophthalmology and Vision Sciences at the University of Toronto. After graduate training in Molecular Neurobiology, she studied Medicine, and is a Fellow of the Royal College of Surgeons of Canada, with specialization in Ophthalmology. She has three Fellowships in Medical Retina, Ocular Pathology, and Cell Biology (Angiogenesis) - the first two from University College London, UK, and the latter from the Scripps Research Institute, California. After less than one year in academia, she accepted the position of Disease Expert with the Novartis Institute of Biomedical Research (NIBR), Basel, Switzerland, where she was Director, world-wide, of the ophthalmology pre-clinical ocular angiogenesis division. She was also head of the NIBR ophthalmology translational program where she was responsible for strategic planning, and importantly, for ensuring that the pre-clinical models and the methodologies used to study them were directly relevant and aligned with clinically available outcome measures. Having returned to the University of Toronto three years ago, she dedicates over 90% of her time to basic research, where she focuses on transgenic models of diabetic retinopathy, acute retinal neurodegeneration, and retinal stem cells. She is currently Founding Director of Toronto's adult Visual Electrophysiology Unit, and within these three years has obtained over $4 million of funding from the CIHR, CHRP (Canadian Health Research Program), the Juvenile Diabetes Research Fund, the Canadian Diabetes Association, and several others.
Shelley Boyd, MD ..., 1 Sept 2006 [cached]
Shelley Boyd, MD (Ophthalmology)
Dr. Boyd comes to St. Michael's Hospital from her position as Clinical Research Fellow at the University College London, Moorfields Eye Hospital, and more recently from her studies at the Scripp's Institute in San Diego.She joins St. Michael's Hospital as a Clinician/Research Scientist in the Department of Ophthalmology, where she will continue her research on cancer angiogenesis.
Other People with the name "Boyd":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.